Fetal hemoglobin levels are related to metabolic control in diabetic subjects

Brazilian Journal of Medical and Biological Research

Volumn 32, Issue 6, 1999, Pages 695-701

  Pardini, V C ^a,b   Victoria I M N ^b   Pieroni, F B ^b   Milagres, C ^b   Nascimento, P D ^c   Velho, G ^d   Purisch, S ^b   Pardini, H ^a,e  

^a Inst de Patol Clin Hermes Pardini   (Brazil)

^b Santa Casa de Belo Horizonte   (Brazil)

^c HOSPITAL FELÍCIO ROCHO   (Brazil)

^d HÔPITAL SAINT VINCENT DE PAUL   (France)

^e Inst de Patologia Clínica ^*  (Brazil)

Author keywords

Diabetes mellitus; Fetal hemoglobin; Glycated hemoglobin; HbA1c; Type 1 diabetes; Type 2 diabetes

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN F;

ADULT; ARTICLE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FETAL HEMOGLOBIN; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED;

EID: 0033145801     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1999000600005     Document Type: Article

References (24)

1. Goldstein DE, Little RR, Wiedmeyer H, England JD & Mackenzie EM (1986). Glycated hemoglobin: methodologies and clinical applications. Clinical Chemistry, 32 (Suppl 1): B64-B70.
2. Cefalu WT, Wang ZQ, Bell-Farrow A, Kiger FD & Izlar C (1994). Glycohemoglobin measured by automated affinity HPLC correlates with both short-term and long-term antecedent glycemia. Clinical Chemistry, 40: 1317-1321.
3. Jovanovic L & Peterson CM (1981). The clinical utility of glycosylated hemoglobin. American Journal of Medicine, 70: 331-338.
4. Larsen ML, Horder M & Mogensen EF (1990). Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus. New England Journal of Medicine, 323: 1021-1025.
5. Rochette J, Craig JE & Thein SL (1994). Fetal hemoglobin levels in adults. Blood Reviews, 8: 213-224.
6. Mullis P, Schuler JJ & Zuppinger K (1989). Increased prevalence of fetal haemoglobin in type 1 (insulin-dependent) diabetes mellitus. Diabetologia, 32: 227-230.
7. Koskinen LK, Latela JT & Koivula TA (1994). Fetal hemoglobin in diabetic patients. Diabetes Care, 17: 828-831.
8. Diem P, Mullis P, Hirt A, Schuler JJ, Burgi W, Zuppinger K & Teuscher A (1993). Fetal haemoglobin levels in adult type 1 (insulin-dependent) diabetic patients. Diabetologia, 36: 129-132.
9. World Health Organisation (1985). Diabetes mellitus. Report of a WHO Study Group. Technical Report Series, WHO, Geneva, No. 727.
10. Betke K, Marti HR & Schlicht I (1959). Estimation of small percentages of fetal haemoglobin. Nature, 184: 1877-1878.
11. Kramer CY (1956). Extension of multiple range tests to group means with unequal numbers of replications. Biometrics, 12: 309-310.
12. Kilpatrick ES, Small M, Rumley A & Dominiczak MH (1993). Increased fetal hemoglobin in insulin-treated diabetes mellitus contributes to the imprecision of glycohemoglobin measurements. Clinical Chemistry, 39: 833-835.
13. Liakopoulou E, Blau CA, Li Q, Josephson B, Wolf JA, Fournarakis B, Aisys V, Dover G, Papayannopoulou T & Stamatoyannopoulos G (1995). Stimulation of fetal hemoglobin production by short chain fatty acids. Blood, 86: 3227-3235.
14. Constantoulakis P, Papayannopoulou T & Stamatoyannopoulos G (1988). Alpha-amino-N-butyric acid stimulates fetal hemoglobin in the adult. Blood, 72: 1961-1967.
15. Stamatoyannopoulos G, Blau CA, Nakamoto B, Josephson B, Li Q, Liakopoulou E, Pace B, Papayannopoulou T, Brusilow SW & Dover G (1994). Fetal hemoglobin induction by acetate, a product of butyrate catabolism. Blood, 84: 3198-3204.
16. Nosadini R, Avogaro A, Doria A, Fioretto F, Trevisan R & Morocutti A (1989). Ketone body metabolism: a physiological and clinical overview. Diabetes/Metabolism Reviews, 5: 299-319.
17. Papadakis M & Grunfeld G (1986). Ketonuria in hospitalized patients with non-insulin-dependent diabetes mellitus, Diabetes Care, 9: 596-600.
18. Cook GA (1987). The hypoglycemic sulfonylurea glyburide and tolbutamide inhibit fatty acid oxidation by inhibiting carnitine palmitoyl-transferase. Journal of Biological Chemistry, 262: 4968-4972.
19. Singh BM, Krentz AJ & Nattrass M (1993). Insulin resistance in the regulation of lipolysis and ketone body metabolism in non-insulin dependent diabetes is apparent at very low insulin concentrations. Diabetes Research and Clinical Practice, 20: 55-62.
20. Avogaro A, Valerio A, Gnudi L, Maran A, Zolli M, Duner E, Riccio A, Del Prato S, Tiengo A & Nosadini R (1992). Ketone body metabolism in NIDDM. Effect of sulfonylurea treatment. Diabetes, 41: 968-974.
21. Avogaro A, Crepaldi C, Miola M, Maran A, Pengo V, Tiengo A & Del Prato S (1996). High blood ketone body concentration in type 2 non-insulin dependent diabetic patients. Journal of Endocrinological Investigation, 19: 99-105.
22. Gruber CA & Krets MD (1979) Quantitation of hemoglobin A1a+b and hemoglobin A1c by automated "high performance• liquid chromatography. Clinical Chemistry, 25: 1970-1971.
23. Bulusu S (1995). Variant haemoglobin may affect measurements. British Medical Journal, 310: 749-751.
24. Goldstein DE & Little RR (1994). More than you ever wanted to know (but need to know) about glycohemoglobin testing (Editorial). Diabetes Care, 17: 938-939.